This company has been acquired
Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
GTHX Stoklara Genel Bakış
A commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer in the United States.
| Kar Tanesi Skoru | |
|---|---|
| Değerleme | 5/6 |
| Gelecekteki Büyüme | 6/6 |
| Geçmiş Performans | 0/6 |
| Finansal Sağlık | 4/6 |
| Temettüler | 0/6 |
Ödüller
Risk Analizi
G1 Therapeutics, Inc. Rakipler
Fiyat Geçmişi ve Performans
| Tarihsel hisse senedi fiyatları | |
|---|---|
| Güncel Hisse Fiyatı | US$7.15 |
| 52 Haftanın En Yüksek Seviyesi | US$7.19 |
| 52 Haftanın En Düşük Seviyesi | US$1.08 |
| Beta | 1.68 |
| 11 Aylık Değişim | 0.85% |
| 3 Aylık Değişim | 182.61% |
| 1 Yıllık Değişim | 433.58% |
| 33 Yıllık Değişim | -52.55% |
| 5 Yıllık Değişim | -78.80% |
| Halka arzdan bu yana değişim | -52.33% |
Son Haberler & Güncellemeler
Recent updates
There's No Escaping G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Muted Revenues Despite A 80% Share Price Rise
Jul 26
G1 Therapeutics: Failure Of Breast Cancer Underscores Long-Term Uncertainty
Jun 24Shareholders May Not Be So Generous With G1 Therapeutics, Inc.'s (NASDAQ:GTHX) CEO Compensation And Here's Why
Jun 07Little Excitement Around G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Revenues
May 28G1 Therapeutics, Inc. (NASDAQ:GTHX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 04Why G1 Therapeutics Is A Speculative 'Buy' In The Oncology Biotech Landscape
Mar 22Why Investors Shouldn't Be Surprised By G1 Therapeutics, Inc.'s (NASDAQ:GTHX) 44% Share Price Plunge
Feb 27Does G1 Therapeutics (NASDAQ:GTHX) Have A Healthy Balance Sheet?
Feb 06G1 Therapeutics, Inc. (NASDAQ:GTHX) Stock Catapults 61% Though Its Price And Business Still Lag The Industry
Jan 04Little Excitement Around G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Revenues
Jun 08New Forecasts: Here's What Analysts Think The Future Holds For G1 Therapeutics, Inc. (NASDAQ:GTHX)
May 08The G1 Therapeutics, Inc. (NASDAQ:GTHX) Analysts Have Been Trimming Their Sales Forecasts
Nov 04G1 Therapeutics: Catalysts Stacking
Oct 20G1 Therapeutics: Building A Franchise
Sep 29Analysts Just Published A Bright New Outlook For G1 Therapeutics, Inc.'s (NASDAQ:GTHX)
Aug 04G1 Therapeutics Q2 2022 Earnings Preview
Aug 02G1 Therapeutics: Take Advantage Of The November Data
Jul 22Hissedar Getirileri
| GTHX | US Biotechs | US Pazar | |
|---|---|---|---|
| 7D | 0.3% | -2.6% | -0.7% |
| 1Y | 433.6% | 17.5% | 30.3% |
Getiri vs. Endüstri: GTHX exceeded the US Biotechs industry which returned 20.4% over the past year.
Getiri vs Piyasa: GTHX exceeded the US Market which returned 25.3% over the past year.
Fiyat Oynaklığı
| GTHX volatility | |
|---|---|
| GTHX Average Weekly Movement | 19.9% |
| Biotechs Industry Average Movement | 10.0% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 15.1% |
| 10% least volatile stocks in US Market | 3.1% |
İstikrarlı Hisse Senedi Fiyatı: GTHX's share price has been volatile over the past 3 months.
Zaman İçindeki Volatilite: GTHX's weekly volatility (20%) has been stable over the past year, but is still higher than 75% of US stocks.
Şirket Hakkında
| Kuruldu | Çalışanlar | CEO | Web sitesi |
|---|---|---|---|
| 2008 | 100 | Jack Bailey | www.g1therapeutics.com |
G1 Therapeutics, Inc. Temel Bilgiler Özeti
| GTHX temel i̇stati̇sti̇kler | |
|---|---|
| Piyasa değeri | US$378.17m |
| Kazançlar(TTM) | -US$44.77m |
| Gelir(TTM) | US$58.20m |
6.5x
P/S Oranı-8.4x
F/K OranıGTHX aşırı değerli mi?
Gerçeğe Uygun Değer ve değerleme analizine bakınızKazanç ve Gelir
| GTHX gelir tablosu (TTM) | |
|---|---|
| Gelir | US$58.20m |
| Gelir Maliyeti | US$6.14m |
| Brüt Kâr | US$52.05m |
| Diğer Giderler | US$96.82m |
| Kazançlar | -US$44.77m |
Son Raporlanan Kazançlar
Jun 30, 2024
Sonraki Kazanç Tarihi
n/a
| Hisse başına kazanç (EPS) | -0.85 |
| Brüt Marj | 89.44% |
| Net Kâr Marjı | -76.93% |
| Borç/Özkaynak Oranı | 180.2% |
GTHX uzun vadede nasıl bir performans gösterdi?
Geçmiş performansı ve karşılaştırmayı görün